Identifying patients at risk of late recovery (≥8 days) from acute exacerbation of chronic bronchitis and COPD

Respiratory Medicine

Volumn 106, Issue 9, 2012, Pages 1258-1267

  Anzueto, Antonio ^a   Miravitlles, Marc ^b   Ewig, Santiago ^c   Legnani, Delfino ^d   Heldner, Stephanie ^e   Stauch, Kathrin ^f  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOSPITAL CLÍNIC   (Spain)

^c Augusta Kranken Anstalt   (Germany)

^d UNIVERSITY OF MILAN   (Italy)

^e BAYER PHARMA AG   (Germany)

^f BAYER AG   (Germany)

Author keywords

AECB; AECOPD; Exacerbation; Moxifloxacin; Non interventional; Observational

Indexed keywords

CORTICOSTEROID; MOXIFLOXACIN;

ADULT; AGED; AGING; AIRWAY OBSTRUCTION; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONVALESCENCE; DEMOGRAPHY; DIARRHEA; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; GEOGRAPHIC ORIGIN; HEART DISEASE; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NAUSEA; OBSERVATIONAL STUDY; OUTPATIENT; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SPIROMETRY; TREATMENT OUTCOME; VOMITING;

ACUTE DISEASE; ADULT; AGED; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BRONCHITIS, CHRONIC; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUINOLINES; RECOVERY OF FUNCTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84864602576     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2012.06.002     Document Type: Article

References (31)

1. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med 3 2006 e442
2. M. Miravitlles, C. Murio, T. Guerrero, R. Gisbert On behalf of the DAFNE study group Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD CHEST 121 2002 1449 1455 (Pubitemid 34499654)
3. M. Miravitlles, E. Monsó, J. Mensa, J. Aguarón Pérez, J. Barberán, and M. Bárcena Caamaño Antimicrobial treatment of exacerbation in chronic obstructive pulmonary disease: 2007 consensus statement Arch Bronconeumol 44 2008 100 108 (Pubitemid 351670869)
4. S.D. Ramsey, and F.D. Hobbs Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease Proc Am Thorac Soc 3 2006 635 640 (Pubitemid 44411633)
5. R. Wilson, P. Jones, T. Schaberg, P. Arvis, I. Duprat-Lomon, P.P. Sagnier MOSAIC Study Group Antibiotic treatment and factors influencing short- and long-term outcomes of acute exacerbations of chronic bronchitis Thorax 61 2006 337 342
6. M. Miravitlles, A. Anzueto, S. Ewig, D. Legnani, and K. Stauch Characterization of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study Ther Adv Respir Dis 3 2009 267 277
7. Y. Feng, F. Jin, S. Mu, H. Shen, H. Shen, X. Yang, and Y. Wang Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study Clin Epidemiol 2 2010 15 21
8. N.R. Anthonisen, J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson Antibiotic therapy in exacerbations of chronic pulmonary disease Ann Intern Med 106 1987 196 204 (Pubitemid 17009877)
9. A. Anzueto, and M. Miravitlles Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD Respir Med 104 2010 1396 1403
10. M. Miravitlles, R. Zalacain, C. Murio, M. Ferrer, J.L. Alvarez-Sala, J.F. Masa On Behalf of the IMPAC study group Speed of recovery from acute exacerbations of COPD after treatment with antimicrobials: results of a two-year study Clin Drug Invest 23 2003 439 450 (Pubitemid 36920516)
11. P. Ball, J.M. Harris, D. Lowson, G. Tillotson, and R. Wilson Acute infective exacerbations of chronic bronchitis Q J Med 88 1995 61 68
12. N.A. Dewan, S. Rafique, B. Kanwar, H. Satpathy, K. Ryschon, G.S. Tillotson, and M.S. Niederman Acute exacerbation of COPD: factors associated with poor treatment outcome CHEST 117 2000 662 671 (Pubitemid 30152203)
13. M. Miravitlles, T. Guerrero, C. Mayordomo, L. Sánchez-Agudo, F. Nicolau, and J.L. Segú Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group Respiration 67 2000 495 501
14. M. Miravitlles, C. Murio, and T. Guerrero Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. A prospective multicenter study in the community Eur Respir J 17 2001 928 933 (Pubitemid 32600341)
15. R. Grossman, J. Mukherjee, D. Vaughan, C. Eastwood, R. Cook, J. LaForge, and N. Lampron A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis CHEST 113 1998 131 141 (Pubitemid 28044936)
16. D. Niewoehner, D. Collins, and M. Erbland Relation to FEV1 of clinical outcomes during exacerbations of chronic obstructive pulmonary disease. The Department of Veterans Affairs Cooperative Study Group Am J Respir Crit Care Med 161 2000 1201 1205 (Pubitemid 30243830)
17. M. Miravitlles, C. Llor, K. Naberan, J.M. Cots, and J. Molina For the EFEMAP study group. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease Resp Med 99 2005 955 965 (Pubitemid 40796538)
18. Available at: Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for the diagnosis [accessed 20.09.11 Manage Prev Chronic Obstructive Lung Dis 2009 http://www.goldcopd.org
19. American Thoracic Society-European Respiratory Society Standards for the diagnosis and management of COPD [accessed 20.09.11 2004 http://www.thoracic. org/clinical/copd-guidelines/resources/copddoc.pdf
20. J. Zielinski, M. Bednarek, D. Gorecka, G. Viegi, S.S. Hurd, and Y. Fukuchi Increasing COPD awareness Eur Resp J 27 2006 833 852 (Pubitemid 44914210)
21. M. Miravitlles, C. de la Roza, K. Naberan, M. Lamban, E. Gobartt, and A. Martín Use of spirometry and patterns of prescribing in COPD in primary care Respir Med 101 2007 1753 1760 (Pubitemid 46947875)
22. C. Pellicer Císcar, J.J. Soler Cataluña, A.L. Andreu Rodríguez, J. Bueso Fabra en representación del Grupo EPOC de Sociedad Valenciana de Neumología Diagnosis of COPD in hospitalised patients Arch Bronconeumol 46 2010 64 69
23. K. Naberan, C. De la Roza, M. Lamban, E. Gobartt, A. Martín, and M. Miravitlles Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care Arch Bronconeumol 42 2006 638 644 (Pubitemid 46132368)
24. M. Monteagudo, T. Rodriguez-Blanco, J. Parcet, N. Peñalver, C. Rubio, M. Ferrer, and M. Miravitlles Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care Arch Bronconeumol 47 2011 226 233
25. M. Miravitlles, F. Kruesmann, D. Haverstock, R. Perroncel, S. Choudhri, and P. Arvis Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis Eur Respir J 39 2012 1354 1360
26. M. Woodhead, F. Blasi, S. Ewig, G. Huchon, M. Ieven, and A. Ortqvist Guidelines for the management of adult lower respiratory tract infections Eur Resp J 26 2005 1138 1180 (Pubitemid 41829947)
27. ALAT Work Group Update to the Latin American thoracic society (ALAT) recommendations on infectious exacerbations of COPD Arch Bronconeumol 40 2004 315 325
28. M. Miravitlles, C. Llor, K. Naberan, J.M. Cots, J. Molina For the EFEMAP Study Group Effect of various microbial regimens on the clinical course of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease in primary care Clin Drug Invest 24 2004 63 72 (Pubitemid 38316595)
29. F. Van Bambeke, and P.M. Tulkens Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes Drug Saf 32 2009 359 378
30. J.R. Hurst, G.C. Donaldson, J.K. Quint, J.J. Goldring, R. Baghai-Ravary, and J.A. Wedzicha Temporal clustering of exacerbations in chronic obstructive pulmonary disease Am J Respir Crit Care Med 179 2009 369 374
31. J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Müllerova, and R. Tal-Singer Susceptibility to exacerbation in chronic obstructive pulmonary disease N Engl J Med 363 2010 1128 1138